Publikationen
Wüster C, Bucher M, Manegold C, Schmidt J, Ziegler R, Drings P (1991)
Methylpentylaminoprolidene Bisphosphonate (BM 210955) in The Treatment of Hypercalcemia of Malignancy
Onkologie 14, Suppl. 3: 20
Badea R, Badea Gh, Galtar N, Craciun C, Marin M, Bucher M (1991)
Die Bedeutung der aspirativen Feinnadelbiopsie in der Präzisierung ultraschalldiagnostizierter Lebertumoren Untersuchungen an 165 Patienten
Z Klin Med 46: 1489-1493
Wüster C, Bucher M, Manegold C, Schmid J (1992)
Methylpenthylaminopropyliden (BM 210955) bei der Behandlung der Tumorhyperkalzämie
J Can Res and Clin Oncol 118, Suppl.: 149
Bucher M, Manegold C, Sterz R, Drings P (1992)
Effectiveness of the new Bisphosphonate BM 21.0955 in
Hypercalcemia of Malignancy in Patients with Lung Cancer
Xlth ICCRH Conference, Satellite Workshop Sienna 1992
Bucher M, Manegold C, Krempien B, Fischer JR, Drings P (1992)
Human Epithelial Antigen (HEA) 125-Postive Cells in the Bone Marrow of Small Cell Lung Cancer (SCLC)
The European Respiratory Journal 5, Suppl. 15 : 382
Bischoff HG, Layer G, Manegold C, Bucher M, Knopp P, Drings P (1992)
Improvement in the Staging of Small Cell Lung Cancer (SCLC) by MRI of Bone Marrow
The European Respiratory Journal 5, Suppl. 15 : 439
Bucher M, Manegold C, Krempien B, Fischer JR, Drings P (1992)
Human Epithelial Antigen (HEA) 125-Positive Cells in the Bone Marrow of Small Cell Lung Cancer (SCLC)
Annals of Hematology 65, Suppl.: 42
Manegold C, Bucher M, Hug G, Drings P (1993)
Phase-II-Study of Oral Ifosfamide (01)/ Mesna (M) in Small Cell Lung Cancer (SCLC)
ASCO Annual Meeting 1993
Bucher M, Manegold C, Sterz R, Drings P (1993)
Effectiveness of the new Bisphosphonate BM 21.0955 in Hypercalcemia of Malignancy in Patients with Lung Cancer
Int. Symposium Supportive Care in Cancer, St. Gallen 1993
Blind E, Kaue F, Meinel T, Bucher M, Manegold C, Ebert W, Vogt-Moykopf I, Ziegler R (1993)
Levels of paratyroid hormone-related protein in Hypercalcemia of malignancy: comparasion of midregional radioimmunassay and two-site immunoradiometric assay
Clin Investig 71: 31-36
Bischoff HG, Knopp MV, Bucher M, Manegold C, van Kaick G, Drings P (1993)
Clinical application of FDG-PET imaging in management of malignant pleural mesothelioma
The European Respiratory Journal 6, Suppl. 17: 140
Bucher M, Manegold C, Krempien B, Drings P (1994)
The role of immunocytological staining on bone marrow aspirates for staging small cell lung cancer (SCLC)
Cancer Research and Clinical Oncology, Vol 120, Suppl: R
Hagemeyer 0, Bucher M, Schrenk B, Bülzebruck H, Drings P, Schulz V (1994)
Correlation between both time of initial diagnosis and survival in lung cancer and profession
Cancer Rearch and Clinical Oncology, Vol 120, Suppl: R 25
Bucher M., Meinel Th., Manegold C., Drings P., Raue F., Herrmann Z (1994)
The new bisphosphonate BM 21.0955 in the treatment of hypercalcemia of malignancy in mallignant mesothelioma
Supp. Care in Cancer New Orleans 1994
Manegold C., Bucher M., Krempien B., Bülzebruck H., Drings P. (1994)
Immunocytological evidence of tumor cells (lETC) spread to bone marrow and its relationship to prognosis in small cell lung cancer cancer (SCLC)
7 th World Conference on Lung Cancer Juni 1994
Bischoff H.G., Bucher M., Knopp M.V., Krempien B., Manegold C. (1994)
Bone marrow MRI and immunocytological staining with HEA- 125 – new tools in staging small cell lung cancer
Onkologie, Band 17, Suppl. 2: 10
Bucher M., Manegold C., Krempien B., Drings P (1994)
Immunocytological staining with HEA-125 on bone marrow aspirates for staging small cell lung cancer
The European Respiratory Journal 7, Suppl. 18: 305
Bucher M., Hagemeyer 0., Bülzebruck H., Drings P., Baur X. (1994)
Besteht ein Zusammnenhang zwischen der beruflichen Tätigkeit und dem Erkrankungsalter sowie der Überlebenszeit beim Bronchialkarzinom
Atemwegs-und Lungenkrankheiten, Heft 11:
Bischoff H.G., Bucher M., Knopp M.V., Krempien B., Manegold C. (1994)
The role of bone marrow MRI and immunocytological staining with HEA-125 in the staging of SCLC
Annals of Oncology 5, Suppl. 8: 163
Bucher M., Manegold C., Krempien B., Drings P. (1994)
Immunocytological staining with HEA-125 on bone marrow aspirates for staging small cell lung cancer (SCLC)
Annals of Oncology 5, Suppl. 8: 163
Kröger H., Klüppelberg F., Manke H.G., Bucher M., Kayser K., Möller P., Manegold C.
Primär pulmonale Lymphome- Beobachtung anhand von 7 Fallbeschreibungen
PAPERS PRESENTED DURING CLINICAL PRACTICE
Methylpentylaminoprolidene bisphosphonate (BM 210955) in the treatment of hypercalcemia of malignancy
AIC Conference Dresden November 1990
Hyperkalzämie-Behandlung beim Bronchialkarzinom
Oberrheinische Arbeitsgruppe für Onkologie
Heidelberg February 1993
Die Rolle immunzytologischer Knochenmarkuntersuchungen bei Patienten mit SCLC21. Deutscher Krebskongress Hamburg 1994
Evaluation and clinical relevance of bone marrow metatasis SCLC
EORTC Meeting Heidelberg October 1994
Klinik bei Bronchialkarzinom: week-long Programme to strengthen public awareness of cancer
DKFZ Heidelberg October 1995